Call it the Industrial Revolution for healthcare, the century of biology, Moore’s Law for medicine, or all three. Whatever metaphor you choose, the meaning is the same: Thanks to our rapidly evolving understanding of biology and the application of new technological tools—and a bit of urgency sparked by the Covid pandemic—explosive change is coming in our ability to diagnose, treat, and even cure many debilitating diseases. Indeed, a golden age could be dawning for patients and healthcare practitioners—and investors in pharmaceutical and biotech stocks.
Along…
